C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 487/04 (2006.01) A61K 31/519 (2006.01) A61K 31/5377 (2006.01) A61P 35/00 (2006.01)
Patent
CA 2671614
This invention relates to novel 2,3-dihydroimidazo[1,2-c]quinazoline compounds, pharmaceutical compositions containing such compounds and the use of those compounds or compositions for phosphotidylinositol-3-kinase (PI3K) inhibition and treating diseases associated with phosphotidylinositol-3-kinase (PI3K) activity, in particular treating hyper-proliferative and/or angiogenesis disorders, as a sole agent or in combination with other active ingredients.
L'invention concerne des composés nouveaux de 2,3-dihydroimidazo[1,2-c]quinazoline, des compositions pharmaceutiques contenant de tels composés et l'utilisation de ces composés ou compositions pour l'inhibition de la phosphotidylinositol-3-kinase (PI3K) et le traitement de maladies associées à l'activité de la phosphotidylinositol-3-kinase (PI3K), en particulier pour le traitement de troubles hyperlifératifs et/ou de l'angiogenèse, en tant qu'agent unique ou en combinaison avec d'autres ingrédients actifs.
Bullion Ann-Marie
Campbell Ann-Marie
Hentemann Martin
Michels Martin
Redman Aniko
Bayer Schering Pharma Aktiengesellschaft
Marks & Clerk
LandOfFree
Substituted 2,3-dihydroimidazo[1,2-c]quinazoline derivatives... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted 2,3-dihydroimidazo[1,2-c]quinazoline derivatives..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted 2,3-dihydroimidazo[1,2-c]quinazoline derivatives... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2060268